F84.5 F31 F32 F20
Conditions
Interventions
Group 1: A stimulus of moving colored dots on a computer screen will be presented to participiants. These dots move from the center outwards and will continously become brighter and larger. This gives
Sponsors
Forschungszentrum Jülich GmbH Institut für Neurowissenschaften und Medizin (INM-3) Kognitive Neurowissenschaft
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: For healthy subjects: -Clinical and anamnestic exclusion from neurological and mental disorders. -No current psychotropic medication. -Age between 18 and 55 years. -Normal or corrected vision. -Legally effective, written consent form of the subject to participation in the study. For groups with diagnosis F84.5 (ASS): -Diagnosed with Asperger's-Syndrome (F84.5) according to the ICD-10. -Clinical and anamnestic exclusion from comorbid neurological and mental disorders. -No current psychotropic medication. -Age between 18 and 55 years. -Normal or corrected vision. -Legally effective, written consent form of the subject to participation in the study. For groups with diagnosis F31 or F32 (Depression): -Diagnosed with Depression (F31 or F32) according to the ICD-10. -Clinical and anamnestic exclusion from comorbid neurological and mental disorders. -Age between 18 and 55 years. -Normal or corrected vision. -Legally effective, written consent form of the subject to participation in the study. For groups with diagnosis F20 (Schizophrenia). -Diagnosed with Schizophrenia (F20) according to the ICD-10. -Clinical and anamnestic exclusion from comorbid neurological and mental disorders. -Age between 18 and 55 years. -Normal or corrected vision. -Legally effective, written consent form of the subject to participation in the study.
Exclusion criteria
Exclusion criteria: Exclusion Criteria for healthy subjects: -Minors and people older than 55 years. -Current or preceding diagnosis of a mental or neurological disorder. -Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.) -Known MRI- or EEG-abnormalities. -Acute suicidal tendency, risk of self-harm or harm to others. -Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG). Exclusion Criteria for patients with Asperger's-Syndrome (F84.5): -Minors and people older than 55 years. -Current or preceding diagnosis of a mental or neurological disorder, but not F84.5. -Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.) -Known MRI- or EEG-abnormalities. -Acute suicidal tendency, risk of self-harm or harm to others. -Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG). Exclusion Criteria for patients with Depression (F31 & F32): -Minors and people older than 55 years. -Current or preceding diagnosis of a mental or neurological disorder, but not F31 or F32. -Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.) -Known MRI- or EEG-abnormalities. -Acute suicidal tendency, risk of self-harm or harm to others. -Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG). Exclusion Criteria for patients with Schizoprenia (F20.x): -Minors and people older than 55 years. -Current or preceding diagnosis of a mental or neurological disorder, but not F20.x. -Existent internal ailments (malignant tumors, HIV-infection: no HIV-tests will be carried out.) -Known MRI- or EEG-abnormalities. -Acute suicidal tendency, risk of self-harm or harm to others. -Missing legally effective, written consent form of subjects to participation in the study, people not qualified for legal acts or those in governmental or judicial custody (PsychKG, BTG).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Goal is the examination of human time perception (duration and passage of time) and the influence of various environmental factors. | — |
Countries
Germany
Contacts
Public ContactMathis Jording
Forschungszentrum Jülich Institut für Neurowissenschaften und Medizin (INM-3)
Outcome results
None listed